CSF1R and central nervous system cancer: The results indicated that combination therapy of RT with CSF-1R inhibition therapy can target and stabilize these pathways, which were elevated in the RT-only therapy and should reflect the underlying mechanism leading to improved survival of glioma mice and human patients.